Impact of COVID-19 Vaccination on Glycemia in Individuals With Type 1 and Type 2 Diabetes: Substudy of the COVAC-DM Study

Diabetes Care. 2022 Feb 1;45(2):e24-e26. doi: 10.2337/dc21-1563.

Felix Aberer^{1

2}, Othmar Moser^{2

3}, Faisal Aziz^{1

2}, Caren Sourij⁴, Haris Ziko¹, Jacqueline Lenz^{1

2}, Farah Abbas^{1

2}, Anna M Obermayer^{1

2}, Harald Kojzar^{1

2}, Peter N Pferschy^{1

2

5}, Alexander Müller^{1

2}, Christina Unteregger^{1

2}, Marlies Leitner^{1

2}, Tamara Banfic^{1

2}, Max L Eckstein³, Nadine Wachsmuth^{1

3}, Susanne Kaser⁶, Julia K Mader¹, Norbert J Tripolt^{1

2}, Harald Sourij^{1

2}

¹ Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.
² Interdisciplinary Metabolic Medicine Trials Unit, Medical University of Graz, Graz, Austria.
³ Department of Exercise Physiology & Metabolism, Institute of Sports Science, University of Bayreuth, Bayreuth, Germany.
⁴ Division of Cardiology, Medical University of Graz, Graz, Austria.
⁵ Center for Biomarker Research in Medicine (CBmed), Graz, Austria.
⁶ Medical University of Innsbruck, Innsbruck, Austria.

No abstract available

Publication types